Home Access Bio

Access Bio

In operation
Post-IPO Round
Molecular Diagnostics Product Developer
Basic
Enterprise Profile

Basic Information

Access Bio is committed to the prevention and early diagnosis of infectious diseases through the research, development, and production of in vitro rapid diagnostic tests, biosensors, and molecular diagnostic products. Based on the greatest needs and potential, Access Bio collaborates with partners worldwide, including the Bill & Melinda Gates Foundation, the World Health Organization, Médecins Sans Frontières, UNICEF, and more.
Access Bio, Inc.
NewJersey,United States of America
less than 15 people
January 01, 2001
info@accessbio.net

Enterprise Profile

Industrial Sector
Medical Device R&D and Design # Diagnostic Manufacturing
Technology
Molecular Diagnostics Sensor Genetic Testing
Concept
Infectious Diseases Department Laboratory Diagnosis
Application Scenarios
Novel Coronavirus Medical Devices Medical Device Consumables Early Disease Screening